SAN JOSE, Calif., March 26, 2018 /PRNewswire/ — ITUS Corporation (NASDAQ: ITUS), a company using the power of the immune system to diagnose and treat cancer, today announced that the United States Patent and Trademark Office (“USPTO”) has issued US Patent No. 9,934,364. This is the…
